katayoun rezvani

katayoun rezvani

UNVERIFIED PROFILE

Are you katayoun rezvani?   Register this Author

Register author
katayoun rezvani

katayoun rezvani

Publications by authors named "katayoun rezvani"

Are you katayoun rezvani?   Register this Author

100Publications

3982Reads

25Profile Views

Human NK Cells Develop an Exhaustion Phenotype During Polar Degranulation at the Hyphal Synapse.

Front Immunol 2018 22;9:2344. Epub 2018 Oct 22.

Faculty of Medicine, Imperial College London, National Heart and Lung Institute, London, United Kingdom.

View Article

Download full-text PDF

Source
https://www.frontiersin.org/article/10.3389/fimmu.2018.02344
Publisher Site
http://dx.doi.org/10.3389/fimmu.2018.02344DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204393PMC
October 2019

Adoptive cell therapy using engineered natural killer cells.

Authors:
Katayoun Rezvani

Bone Marrow Transplant 2019 Aug;54(Suppl 2):785-788

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-019-0601-6DOI Listing
August 2019

Mesenchymal stem cell-derived exosomes for clinical use.

Bone Marrow Transplant 2019 Aug;54(Suppl 2):789-792

Stem Cell Transplantation, MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41409-019-0616-z
Publisher Site
http://dx.doi.org/10.1038/s41409-019-0616-zDOI Listing
August 2019

Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer.

Front Immunol 2018 15;9:283. Epub 2018 Feb 15.

MD Anderson Cancer Center, Houston, TX, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2018.00283DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818392PMC
March 2019

Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid Leukemia.

Biol Blood Marrow Transplant 2019 03 9;25(3):505-514. Epub 2018 Oct 9.

Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, University of Texas, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791183059
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2018.09.032DOI Listing
March 2019

Cord Blood Expansion: A Clinical Advance.

J Clin Oncol 2019 Feb 21;37(5):363-366. Epub 2018 Dec 21.

1 The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.18.01789DOI Listing
February 2019

Allogeneic BK Virus-Specific T Cells for PML.

N Engl J Med 2019 01;380(1):106

M.D. Anderson Cancer Center, Houston, TX

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMc1815050
Publisher Site
http://dx.doi.org/10.1056/NEJMc1815050DOI Listing
January 2019

The Other Side of CAR T-Cell Therapy: Cytokine Release Syndrome, Neurologic Toxicity, and Financial Burden.

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:433-444. Epub 2019 May 17.

3 The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_238691DOI Listing
January 2019

Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy.

N Engl J Med 2018 10;379(15):1443-1451

From the Departments of Stem Cell Transplantation and Cellular Therapy (M.M., A.O., D.M., S.A., I.K., L.L., R.C., E.J.S., K.R.), Infectious Diseases (V.M.), Neuro-Oncology (S.T.), Diagnostic Radiology (T.L.C.), and Leukemia (A.F.), M.D. Anderson Cancer Center, Houston.

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1801540
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1801540DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283403PMC
October 2018

Graft loss attributed to possible transfusion-transmitted ehrlichiosis following cord blood stem cell transplant.

Transpl Infect Dis 2018 Aug 7;20(4):e12899. Epub 2018 May 7.

Department of Infectious Diseases, Infection Control and Employee Health, Division of Internal Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/tid.12899
Publisher Site
http://dx.doi.org/10.1111/tid.12899DOI Listing
August 2018

Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering.

Curr Opin Immunol 2018 04 30;51:146-153. Epub 2018 Mar 30.

Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, University of Texas, Houston, TX, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.coi.2018.03.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140331PMC
April 2018

Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.

Authors:
Nimitha R Mathew Francis Baumgartner Lukas Braun David O'Sullivan Simone Thomas Miguel Waterhouse Tony A Müller Kathrin Hanke Sanaz Taromi Petya Apostolova Anna L Illert Wolfgang Melchinger Sandra Duquesne Annette Schmitt-Graeff Lena Osswald Kai-Li Yan Arnim Weber Sonia Tugues Sabine Spath Dietmar Pfeifer Marie Follo Rainer Claus Michael Lübbert Christoph Rummelt Hartmut Bertz Ralph Wäsch Johanna Haag Andrea Schmidts Michael Schultheiss Dominik Bettinger Robert Thimme Evelyn Ullrich Yakup Tanriver Giang Lam Vuong Renate Arnold Philipp Hemmati Dominik Wolf Markus Ditschkowski Cordula Jilg Konrad Wilhelm Christian Leiber Sabine Gerull Jörg Halter Claudia Lengerke Thomas Pabst Thomas Schroeder Guido Kobbe Wolf Rösler Soroush Doostkam Stephan Meckel Kathleen Stabla Stephan K Metzelder Sebastian Halbach Tilman Brummer Zehan Hu Joern Dengjel Björn Hackanson Christoph Schmid Udo Holtick Christof Scheid Alexandros Spyridonidis Friedrich Stölzel Rainer Ordemann Lutz P Müller Flore Sicre-de-Fontbrune Gabriele Ihorst Jürgen Kuball Jan E Ehlert Daniel Feger Eva-Maria Wagner Jean-Yves Cahn Jacqueline Schnell Florian Kuchenbauer Donald Bunjes Ronjon Chakraverty Simon Richardson Saar Gill Nicolaus Kröger Francis Ayuk Luca Vago Fabio Ciceri Antonia M Müller Takeshi Kondo Takanori Teshima Susan Klaeger Bernhard Kuster Dennis Dong Hwan Kim Daniel Weisdorf Walter van der Velden Daniela Dörfel Wolfgang Bethge Inken Hilgendorf Andreas Hochhaus Geoffroy Andrieux Melanie Börries Hauke Busch John Magenau Pavan Reddy Myriam Labopin Joseph H Antin Andrea S Henden Geoffrey R Hill Glen A Kennedy Merav Bar Anita Sarma Donal McLornan Ghulam Mufti Betul Oran Katayoun Rezvani Omid Shah Robert S Negrin Arnon Nagler Marco Prinz Andreas Burchert Andreas Neubauer Dietrich Beelen Andreas Mackensen Nikolas von Bubnoff Wolfgang Herr Burkhard Becher Gerard Socié Michael A Caligiuri Eliana Ruggiero Chiara Bonini Georg Häcker Justus Duyster Jürgen Finke Erika Pearce Bruce R Blazar Robert Zeiser

Nat Med 2018 Apr;24(4):526

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm0418-526cDOI Listing
April 2018

NK cell therapy for hematologic malignancies.

Int J Hematol 2018 Mar 27;107(3):262-270. Epub 2018 Jan 27.

Department of Stem Cell Transplant and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Unit 0423, 1515 Holcombe Blvd., Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-018-2407-5DOI Listing
March 2018

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.

Authors:
Nimitha R Mathew Francis Baumgartner Lukas Braun David O'Sullivan Simone Thomas Miguel Waterhouse Tony A Müller Kathrin Hanke Sanaz Taromi Petya Apostolova Anna L Illert Wolfgang Melchinger Sandra Duquesne Annette Schmitt-Graeff Lena Osswald Kai-Li Yan Arnim Weber Sonia Tugues Sabine Spath Dietmar Pfeifer Marie Follo Rainer Claus Michael Lübbert Christoph Rummelt Hartmut Bertz Ralph Wäsch Johanna Haag Andrea Schmidts Michael Schultheiss Dominik Bettinger Robert Thimme Evelyn Ullrich Yakup Tanriver Giang Lam Vuong Renate Arnold Philipp Hemmati Dominik Wolf Markus Ditschkowski Cordula Jilg Konrad Wilhelm Christian Leiber Sabine Gerull Jörg Halter Claudia Lengerke Thomas Pabst Thomas Schroeder Guido Kobbe Wolf Rösler Soroush Doostkam Stephan Meckel Kathleen Stabla Stephan K Metzelder Sebastian Halbach Tilman Brummer Zehan Hu Joern Dengjel Björn Hackanson Christoph Schmid Udo Holtick Christof Scheid Alexandros Spyridonidis Friedrich Stölzel Rainer Ordemann Lutz P Müller Flore Sicre-de-Fontbrune Gabriele Ihorst Jürgen Kuball Jan E Ehlert Daniel Feger Eva-Maria Wagner Jean-Yves Cahn Jacqueline Schnell Florian Kuchenbauer Donald Bunjes Ronjon Chakraverty Simon Richardson Saar Gill Nicolaus Kröger Francis Ayuk Luca Vago Fabio Ciceri Antonia M Müller Takeshi Kondo Takanori Teshima Susan Klaeger Bernhard Kuster Dennis Dong Hwan Kim Daniel Weisdorf Walter van der Velden Daniela Dörfel Wolfgang Bethge Inken Hilgendorf Andreas Hochhaus Geoffroy Andrieux Melanie Börries Hauke Busch John Magenau Pavan Reddy Myriam Labopin Joseph H Antin Andrea S Henden Geoffrey R Hill Glen A Kennedy Merav Bar Anita Sarma Donal McLornan Ghulam Mufti Betul Oran Katayoun Rezvani Omid Shah Robert S Negrin Arnon Nagler Marco Prinz Andreas Burchert Andreas Neubauer Dietrich Beelen Andreas Mackensen Nikolas von Bubnoff Wolfgang Herr Burkhard Becher Gerard Socié Michael A Caligiuri Eliana Ruggiero Chiara Bonini Georg Häcker Justus Duyster Jürgen Finke Erika Pearce Bruce R Blazar Robert Zeiser

Nat Med 2018 03 12;24(3):282-291. Epub 2018 Feb 12.

Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm.4484DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029618PMC
March 2018

Chimeric antigen receptor T-cell therapy - assessment and management of toxicities.

Nat Rev Clin Oncol 2018 Jan 19;15(1):47-62. Epub 2017 Sep 19.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2017.148DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733403PMC
January 2018

New and emerging therapies for acute and chronic graft host disease.

Ther Adv Hematol 2018 Jan 28;9(1):21-46. Epub 2017 Nov 28.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 0423, Houston, TX 77030-4000, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620717741860DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753923PMC
January 2018

Engineering Natural Killer Cells for Cancer Immunotherapy.

Mol Ther 2017 08 28;25(8):1769-1781. Epub 2017 Jun 28.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymthe.2017.06.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542803PMC
August 2017

Immunotherapy for infectious diseases in haematological immunocompromise.

Br J Haematol 2017 05 29;177(3):348-356. Epub 2017 Mar 29.

Fungal Pathogens Laboratory, National Heart and Lung Institute, Imperial College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14595DOI Listing
May 2017

Can we make a better match or mismatch with KIR genotyping?

Hematology Am Soc Hematol Educ Program 2016 Dec;2016(1):106-118

Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2016.1.106DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142490PMC
December 2016

Immune reconstitution post allogeneic transplant and the impact of immune recovery on the risk of infection.

Virulence 2016 11 6;7(8):901-916. Epub 2016 Jul 6.

b Department of Stem Cell Transplantation and Cellular Therapy , MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/21505594.2016.1208866DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5160395PMC
November 2016

PR1-specific cytotoxic T lymphocytes are relatively frequent in umbilical cord blood and can be effectively expanded to target myeloid leukemia.

Cytotherapy 2016 08;18(8):995-1001

Section of Transplantation Immunology, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcyt.2016.05.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934389PMC
August 2016

Epstein-Barr Virus and B Cells in the Pathogenesis of Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem-Cell Transplantation.

J Clin Oncol 2016 07 18;34(19):2201-2. Epub 2016 Apr 18.

The University of Texas MD Anderson Cancer Center, Houston, TX

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.6099DOI Listing
July 2016

Optimal Threshold and Time of Absolute Lymphocyte Count Assessment for Outcome Prediction after Bone Marrow Transplantation.

Biol Blood Marrow Transplant 2016 Mar 31;22(3):505-13. Epub 2015 Oct 31.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791150070
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2015.10.020DOI Listing
March 2016

Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia.

Biol Blood Marrow Transplant 2016 Jan 4;22(1):47-53. Epub 2015 Sep 4.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas; Transplant Myeloid Study Group, Department of Stem Cell Transplant and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.08.031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892364PMC
January 2016

Cord Blood as a Source of Natural Killer Cells.

Front Med (Lausanne) 2015 5;2:93. Epub 2016 Jan 5.

Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center , Houston, TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fmed.2015.00093DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700256PMC
January 2016

The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer.

Front Immunol 2015 17;6:578. Epub 2015 Nov 17.

Department of Pediatrics, Texas Children's Cancer and Hematology Centers, Baylor College of Medicine , Houston, TX , USA ; Center for Cell and Gene Therapy, Baylor College of Medicine Houston Methodist Hospital and Texas Children's Hospital , Houston, TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2015.00578DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648067PMC
December 2015

Novel Techniques for Ex Vivo Expansion of Cord Blood: Clinical Trials.

Front Med (Lausanne) 2015 11;2:89. Epub 2015 Dec 11.

Division of Cancer Medicine, Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center , Houston, TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fmed.2015.00089DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675847PMC
December 2015

Acute exercise preferentially redeploys NK-cells with a highly-differentiated phenotype and augments cytotoxicity against lymphoma and multiple myeloma target cells. Part II: impact of latent cytomegalovirus infection and catecholamine sensitivity.

Brain Behav Immun 2015 Oct 9;49:59-65. Epub 2015 Jan 9.

Laboratory of Integrated Physiology, Department of Health and Human Performance, University of Houston, 3855 Holman Street, Houston, TX 77204, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbi.2014.12.027DOI Listing
October 2015

Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cells.

Stem Cell Res 2015 Jan 6;14(1):95-104. Epub 2014 Dec 6.

Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scr.2014.11.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634876PMC
January 2015

Concise review: umbilical cord blood transplantation: past, present, and future.

Stem Cells Transl Med 2014 Dec 5;3(12):1435-43. Epub 2014 Nov 5.

Department of Hematology-Oncology, Banner MD Anderson Cancer Center, Gilbert, Arizona, USA; Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Hospital System, and Department of Pediatrics and Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, D.C., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5966/sctm.2014-0151DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250219PMC
December 2014

Opportunities and limitations of natural killer cells as adoptive therapy for malignant disease.

Cytotherapy 2014 Nov 20;16(11):1453-1466. Epub 2014 May 20.

Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, Texas, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcyt.2014.03.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190023PMC
November 2014

Low rate of infusional toxicity after expanded cord blood transplantation.

Cytotherapy 2014 Aug 28;16(8):1153-7. Epub 2014 Feb 28.

Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcyt.2013.12.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4087060PMC
August 2014

Acute exercise preferentially redeploys NK-cells with a highly-differentiated phenotype and augments cytotoxicity against lymphoma and multiple myeloma target cells.

Brain Behav Immun 2014 Jul 5;39:160-71. Epub 2013 Nov 5.

Laboratory of Integrated Physiology, Department of Health and Human Performance, University of Houston, 3855 Holman Street, Houston, TX 77204, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbi.2013.10.030DOI Listing
July 2014

Lenalidomide-induced graft-vs.-Leukemia effect in a patient with chronic lymphocytic leukemia who relapsed after allogeneic stem cell transplant.

Clin Lymphoma Myeloma Leuk 2014 Jun 27;14(3):e105-9. Epub 2013 Dec 27.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2013.12.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840930PMC
June 2014

STAT3: the "Achilles" heel for AML?

Blood 2014 Jan;123(1):1-2

MD ANDERSON CANCER CENTER;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-11-537092DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879899PMC
January 2014

Cancer vaccines and T cell therapy.

Biol Blood Marrow Transplant 2013 Jan 3;19(1 Suppl):S97-S101. Epub 2012 Oct 3.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2012.09.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313548PMC
January 2013

Posttransplantation vaccination: concepts today and on the horizon.

Authors:
Katayoun Rezvani

Hematology Am Soc Hematol Educ Program 2011 ;2011:299-304

Hammersmith Hospital, Imperial College, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2011.1.299DOI Listing
April 2012

Aurora: a new direction for a new dawn.

Authors:
Katayoun Rezvani

Blood 2012 Jan;119(2):322-3

Hammersmith Hospital, UK.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2011-11-38
Publisher Site
http://dx.doi.org/10.1182/blood-2011-11-389452DOI Listing
January 2012

MAGE: the spell is broken.

Authors:
Katayoun Rezvani

Clin Cancer Res 2011 Nov 8;17(22):6955-7. Epub 2011 Nov 8.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-11-2302DOI Listing
November 2011

CD40-ligand/interleukin-2 vaccines in chronic lymphocytic leukemia: the impact of vaccine design.

Authors:
Katayoun Rezvani

Cytotherapy 2011 Oct;13(9):1029-30

Imperial College, Hammersmith Campus, London, UK.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14653249117058
Publisher Site
http://dx.doi.org/10.3109/14653249.2011.605296DOI Listing
October 2011

Vaccination strategies in lymphomas and leukaemias: recent progress.

Drugs 2011 Sep;71(13):1659-74

Department of Haematology, Hammersmith Hospital, Imperial College, London, UK.

View Article

Download full-text PDF

Source
http://link.springer.com/10.2165/11593270-000000000-00000
Publisher Site
http://dx.doi.org/10.2165/11593270-000000000-00000DOI Listing
September 2011

Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients.

Biol Blood Marrow Transplant 2011 May 21;17(5):591-7. Epub 2010 Aug 21.

Hematology and Stem Cell Transplantation Section, Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee 37232-5505, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S108387911000346
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2010.08.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763478PMC
May 2011